The Impact of Potassium Dynamics on Cardiomyocyte Beating in Hemodialysis Treatment

Hiroyuki Hamada1, Tadashi Tomo2, Sung-Teh Kim3

  • 1Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka-City 819-0395, Japan.

PubMed

Insights

Excessive decreases in plasma potassium (KP) during hemodialysis destabilize heart function by impairing cardiomyocyte excitability. Maintaining optimal KP levels is crucial for cardiac stability during dialysis treatment.

Area of Science:

  • Cardiology
  • Nephrology
  • Computational Biology

Background:

  • Observational studies link excessive plasma potassium (KP) decrease during hemodialysis to cardiac dysfunction.
  • Understanding the mechanism of KP reduction on myocardial excitation is vital for dialysis prescription design.

Purpose of the Study:

  • To investigate the relationship between plasma potassium (KP) dynamics and cardiomyocyte excitability using an electrophysiological mathematical model.
  • To elucidate the mechanisms by which decreased KP affects cardiac function.

Main Methods:

  • Development and application of an electrophysiological mathematical model.
  • Simulation of cardiomyocyte behavior under varying KP concentrations.

Main Results:

  • Excessive KP decrease prolonged ventricular cell depolarization by reducing Kr channel potassium efflux, temporarily increasing contraction.
  • Reduced KP activated K+ and Na+ transport via the funny channel in sinoatrial nodal cells, disrupting automaticity.
  • Lower KP levels significantly decreased ventricular cell resting membrane potential, leading to contractile dysfunction.

Conclusions:

  • Avoiding excessive KP decrease during hemodialysis is essential for maintaining cardiomyocyte excitability.
  • Personalized dialysis prescriptions or optimal control of dialysate potassium based on predialysis KP are necessary.
  • Regulatory science in dialysis treatment should focus on managing KP levels to prevent cardiac complications.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
527
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
510